Sakura Finetek Europe launches Tissue-Tek SmartConnect®, a new chapter in automation and the next step for laboratories in achieving future-proof pathology

26 October 2020
Sakura Finetek Europe launches Tissue-Tek SmartConnect®, a new chapter in automation and the next step for laboratories in achieving future-proof pathology
News
0
 Today Sakura Finetek Europe launches its latest innovation Tissue-Tek SmartConnect. An automated transfer system that creates a continuous flow between the SMART solutions Tissue-Tek Xpress® x120 Rapid Tissue Processor and Tissue-Tek AutoTEC® a120 Automated Embedding System.
This new innovative SMART solution enables a laboratory to optimise their workflow and work more efficient, eliminating repetitive and unnecessary manual work. Hence laboratory technicians can focus more on what matters most: taking care of the best possible patient journey.
Tissue-Tek SmartConnect is the first Sakura Finetek Europe launch from their European research & development department. “Our team has done an outstanding job by creating this complex robotic solution in just two years with the extreme high-quality Sakura Finetek is known for. We created a fully automated process, starting with grossed tissues as input up to embedded blocks as output.” Andries Dragt, Vice President, Strategy & Business Development and founder of the idea, is very proud of Sakura Finetek’s European team. “With Tissue-Tek SmartConnect, Sakura Finetek once again proves itself as one of the most innovative companies when it comes to automating and standardising histology laboratories. This solution is a unique step towards future-proof pathology and enables lab technician to spend more of their valuable time on what really matters.” he adds.
In the coming months, the first histology laboratory will be equipped with Tissue-Tek SmartConnect to show its value and support the lab technicians in the workplace. This step is in line with our promise to empower pathology professionals to deliver accurate and fast diagnoses to optimise treatment success,” Chris Koeman, President of Sakura Finetek European states “The patient drives this promise. Because when it comes to diagnosing cancer, there is no time to wait. We truly believe we can make more valuable differences for patients in the future, and that drives us to put all our effort into bringing more worthy innovations to the market.”

Discover more on www.sakura.eu/smartconnect

Condividi questo articolo
Share on FacebookTweet about this on TwitterShare on LinkedInEmail this to someone

Leave a Reply

Your email address will not be published. Required fields are marked *

I cookie ci aiutano a fornire i nostri servizi. Utilizzando tali servizi, accetti l'utilizzo dei cookie da parte di TecnoPlast maggiori informazioni

TecnoPlast utilizza i cookie per fonire la migliore esperienza di navigazione possibile. Continuando a utilizzare questo sito senza modificare le impostazioni dei cookie o premendo su "Accetta" permetti il loro utilizzo.

Chiudi